R. Adam

发表

Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes

F. Pépin, M. Hallett, N. Bertos, 2011, Oncogene.

Short‐ and Long‐term Donor Morbidity in Right Lobe Living Donor Liver Transplantation: 91 Consecutive Cases in a European Center

D. Samuel, F. Saliba, R. Adam, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?

P. Innominato, A. Lemoine, J. Hamelin, 2015, Targeted Oncology.

Repeat hepatectomy for recurrent colorectal metastases

R. J. Haas, R. Adam, D. Azoulay, 2013, The British journal of surgery.

Immunohistochemical variability of epidermal growth factor receptor (EGFR) in liver metastases from colonic carcinomas

B. Falissard, C. Guettier, M. Bralet, 2007, Histopathology.

Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer.

F. Lévi, P. Rougier, M. Bouchahda, 2011, European journal of cancer.

Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases

R. J. Haas, F. Lévi, D. Gorden, 2011, The British journal of surgery.

Long‐term outcome in patients with adrenal metastases following resection of colorectal liver metastases

D. Azoulay, D. Castaing, R. Adam, 2009, The British journal of surgery.

Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.

S. Truant, F. Pruvot, B. Gayet, 2021, The British journal of surgery.

Impact of portal vein embolization on long‐term survival of patients with primarily unresectable colorectal liver metastases

R. J. Haas, D. Azoulay, D. Castaing, 2010, The British journal of surgery.

Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two‐stage hepatectomy for colorectal liver metastases

H. Baba, K. Imai, E. Vibert, 2016, The British journal of surgery.

Large hepatocellular carcinoma: Does fibrosis really impact prognosis after resection?

E. Vibert, J. Mabrut, P. Merle, 2018, Journal of visceral surgery.

Three-drug chronotherapy via hepatic artery as salvage treatment for patients with liver-only metastases from colorectal cancer

F. Lévi, S. Giacchetti, C. Jasmin, 2005 .

Resection of non resectable liver metastases after chemotherapy: Prognostic factors and long term results

F. Lévi, H. Bismuth, S. Giachetti, 2004 .

Effective salvage therapy of liver-only colorectal cancer metastases with chronomodulated irinotecan-fluorouracil-oxaliplatin via hepatic artery infusion.

F. Lévi, S. Giacchetti, C. Jasmin, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation

H. Bismuth, B. Falissard, E. Marchadier, 2000, Histopathology.

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

F. Lévi, S. Giacchetti, C. Focan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemotherapy response influences outcomes in non‐colorectal, non‐neuroendocrine liver metastases

E. Vibert, V. Karam, A. Kalil, 2018, The British journal of surgery.

Phase I II M ulticenter R andomized T rial o f O xaliplatin Added t o C hronomodulated F luorouracil-Leu covorin a s First-Line T reatment o f M etastatic C olorectal C ancer

S. Giacchetti, C. Focan, P. Chollet, 2000 .

Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.

F. Lévi, E. Vibert, C. Guettier, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases

K. Hasegawa, H. Baba, D. Elias, 2019, BJS open.

Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension

M. Miyazaki, H. Bismuth, E. Vibert, 2017, The British journal of surgery.

Long‐term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases

H. Baba, K. Imai, H. Baba, 2017, The British journal of surgery.

Is it possible to predict severe macrovesicular steatosis with liver to spleen ratio and body mass index

E. Vibert, A. S. Cunha, D. Castaing, 2016 .

Risk score to predict biliary leakage after elective liver resection

F. Pruvot, O. Farges, J. Regimbeau, 2018, The British journal of surgery.

Authors' reply: Long‐term outcome in patients with adrenal metastases following resection of colorectal liver metastases (Br J Surg 2009; 96: 935–940)

R. Adam, R. D. de Haas, D. Wicherts, 2010 .

Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre survey

S. Truant, F. Pruvot, B. Gayet, 2020, The British journal of surgery.

Bringing unresectable liver disease to resection with curative intent.

R. J. Haas, R. Adam, R. Adam, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.

S. Truant, F. Pruvot, O. Farges, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.

F. Kreutz, F. Lévi, H. Bismuth, 1999, Anti-cancer drugs.

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases

E. Vibert, A. S. Cunha, A. Lemoine, 2014, British Journal of Cancer.

PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.

T. Gruenberger, J. Figueras, G. Poston, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Long-term outcomes of patients with 10 or more colorectal liver metastases

I. Popescu, T. Gruenberger, F. Giuliante, 2017, British Journal of Cancer.

Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases

H. Bismuth, H. Baba, K. Imai, 2016, The British journal of surgery.

High intra‐abdominal pressure during experimental laparoscopic liver resection reduces bleeding but increases the risk of gas embolism (Br J Surg 2011; 98: 845–852)

E. Vibert, R. Adam, R. Adam, 2011 .

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.

F. Lévi, H. Bismuth, S. Giacchetti, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Vinflunine in patients with advanced unresectable hepatocellular carcinoma and liver impairment

F. Saliba, D. Azoulay, D. Castaing, 2007 .

Optimal control of liver metastases with intravenous cetuximab and hepatic artery infusion of three-drug chemotherapy in patients with liver-only metastases from colorectal cancer: A European multicenter phase II trial.

M. Ducreux, F. Lévi, P. Rougier, 2010 .